stella
beta
Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis — Stella
Recruiting
Back to Bacterial Keratitis trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(1 site)
China
Eye & ENT Hospital of Fudan University, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov